The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration

Ralf Paus, K. S. Stenn, R. E. Link

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

One clinical complication of immunosuppressive cyclosporine A (CsA) therapy is the stimulation of hair growth. Since few pharmacologic agents cause hypertrichosis, CsA appears particularly interesting for investigating the mechanisms which control normal hair formation. Previous investigators have shown that CsA affects the hair growth of the laboratory rat, several genetic variants of mice, as well as humans, and they have concluded that CsA influences keratinization predominantly. Using a well-defined in vivo assay which measures the induction of hair follicle growth, we report here that CsA induces resting (telogen) follicles to enter active growth (anagen) in normal laboratory mice (C57 B1-6), i.e., animals with a normal hair cycle. The experiments indicate that the rate of anagen induction is dependent on the dose, time course, and method of administration and that it may be mediated via a direct action of CsA on the skin and its appendages. These studies suggest that understanding the molecular mechanisms of CsA action on hair growth will help elucidate the mechanisms of normal anagen induction.

Original languageEnglish (US)
Pages (from-to)365-369
Number of pages5
JournalLaboratory Investigation
Volume60
Issue number3
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Hair
Cyclosporine
Skin
Growth
Hypertrichosis
Hair Follicle
Immunosuppressive Agents
Research Personnel

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration. / Paus, Ralf; Stenn, K. S.; Link, R. E.

In: Laboratory Investigation, Vol. 60, No. 3, 01.01.1989, p. 365-369.

Research output: Contribution to journalArticle

@article{837e3b6f698b4f50b7475004f4224ed2,
title = "The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration",
abstract = "One clinical complication of immunosuppressive cyclosporine A (CsA) therapy is the stimulation of hair growth. Since few pharmacologic agents cause hypertrichosis, CsA appears particularly interesting for investigating the mechanisms which control normal hair formation. Previous investigators have shown that CsA affects the hair growth of the laboratory rat, several genetic variants of mice, as well as humans, and they have concluded that CsA influences keratinization predominantly. Using a well-defined in vivo assay which measures the induction of hair follicle growth, we report here that CsA induces resting (telogen) follicles to enter active growth (anagen) in normal laboratory mice (C57 B1-6), i.e., animals with a normal hair cycle. The experiments indicate that the rate of anagen induction is dependent on the dose, time course, and method of administration and that it may be mediated via a direct action of CsA on the skin and its appendages. These studies suggest that understanding the molecular mechanisms of CsA action on hair growth will help elucidate the mechanisms of normal anagen induction.",
author = "Ralf Paus and Stenn, {K. S.} and Link, {R. E.}",
year = "1989",
month = "1",
day = "1",
language = "English (US)",
volume = "60",
pages = "365--369",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration

AU - Paus, Ralf

AU - Stenn, K. S.

AU - Link, R. E.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - One clinical complication of immunosuppressive cyclosporine A (CsA) therapy is the stimulation of hair growth. Since few pharmacologic agents cause hypertrichosis, CsA appears particularly interesting for investigating the mechanisms which control normal hair formation. Previous investigators have shown that CsA affects the hair growth of the laboratory rat, several genetic variants of mice, as well as humans, and they have concluded that CsA influences keratinization predominantly. Using a well-defined in vivo assay which measures the induction of hair follicle growth, we report here that CsA induces resting (telogen) follicles to enter active growth (anagen) in normal laboratory mice (C57 B1-6), i.e., animals with a normal hair cycle. The experiments indicate that the rate of anagen induction is dependent on the dose, time course, and method of administration and that it may be mediated via a direct action of CsA on the skin and its appendages. These studies suggest that understanding the molecular mechanisms of CsA action on hair growth will help elucidate the mechanisms of normal anagen induction.

AB - One clinical complication of immunosuppressive cyclosporine A (CsA) therapy is the stimulation of hair growth. Since few pharmacologic agents cause hypertrichosis, CsA appears particularly interesting for investigating the mechanisms which control normal hair formation. Previous investigators have shown that CsA affects the hair growth of the laboratory rat, several genetic variants of mice, as well as humans, and they have concluded that CsA influences keratinization predominantly. Using a well-defined in vivo assay which measures the induction of hair follicle growth, we report here that CsA induces resting (telogen) follicles to enter active growth (anagen) in normal laboratory mice (C57 B1-6), i.e., animals with a normal hair cycle. The experiments indicate that the rate of anagen induction is dependent on the dose, time course, and method of administration and that it may be mediated via a direct action of CsA on the skin and its appendages. These studies suggest that understanding the molecular mechanisms of CsA action on hair growth will help elucidate the mechanisms of normal anagen induction.

UR - http://www.scopus.com/inward/record.url?scp=0024500610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024500610&partnerID=8YFLogxK

M3 - Article

VL - 60

SP - 365

EP - 369

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 3

ER -